Results 161 to 170 of about 9,315 (207)

Disrupted Vitamin D Signaling and Metabolism in Neurodevelopmental and Neurodegenerative Disorders. [PDF]

ASN Neuro
Khatibi N, MacDonald JL.
europepmc   +1 more source

Sevelamer inhibits the formation of cholesterol gallstones by modulating bile acid metabolism. [PDF]

Front Pharmacol
Shen S, Ning M, Li M, Qian S, Ye X, Zhuang Q, Wu S, Wan X, Dong Z.   +8 more
europepmc   +1 more source

Long-term Western diet feeding impairs hepatic vitamin D metabolism and promotes bone loss in mice. [PDF]

EXCLI J
Zhou P, Hammour MM, Aspera-Werz RH, Ehnert S, Myllys M, Hobloss Z, Hassan R, Gonzalez D, Hendawi R, Edlund K, Hans S, Laschke MW, Ghallab A, Hengstler JG, Nüssler AK, Maisenbacher TC.   +15 more
europepmc   +1 more source

FDA Approves First Targeted Treatment for Cerebrotendinous Xanthomatosis: A Perspective on a Landmark in Rare Lipid Storage Disease Therapy. [PDF]

Health Sci Rep
Jalal L, Basaria AAA, Yokolo H.
europepmc   +1 more source

Smilax china L. Extract Alleviates Metabolic-Associated Fatty Liver Disease by Regulating Gut Microbiota and Bile Acid Metabolism. [PDF]

Metabolites
Cheng S, Li H, Sun Z, Xiong Y, Li J, Tian J, Shen Y, Shen L, Yang J, Yang Y, Liu D, Wei Q, Huang C, Ye X.   +13 more
europepmc   +1 more source

Sustained hyperuricemia disrupts enterohepatic circulation through 12α-hydroxy BA and gut microbiota. [PDF]

Front Microbiol
Zou T, Zhang R, Chen Z, Duan H, Wang Z, Gao R, Chen X, Wang H, Zhao Y, Wang X, Xing S.   +10 more
europepmc   +1 more source

TLR4 modulates simvastatin's impact on HDL cholesterol and glycemic control. [PDF]

Front Pharmacol
Tian X, Zhang P.
europepmc   +1 more source

Genome-scale metabolic modeling and machine learning unravel metabolic reprogramming and mast cell role in lung cancer: a multi-level analysis. [PDF]

Transl Lung Cancer Res
Tabibian M, Razmpour T, Saha R.
europepmc   +1 more source

Dietary ω-3 polyunsaturated fatty acids (PUFAs) reduce cholesterol-driven non-small cell lung cancer (NSCLC) progression in mouse models of disease. [PDF]

Commun Med (Lond)
Harre P, Hohenberger K, Krammer S, Yang Z, Tausche P, Willar J, Trufa DI, Chiriac MT, Geppert CI, Rauh M, Hildner K, Hartmann A, Sirbu H, Finotto S.   +13 more
europepmc   +1 more source